Breast Neoplasms: all 12,820 studies
Page 20 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before SurgeryRecruitingNCT06127979Not applicable
- Surveillance MRI Registry for Patients Who Had Breast Cancer With Dense Breast TissueRecruitingNCT06127797
- Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Progressive Disease After TKIs or HP TherapyRecruitingNCT06125834Phase 2
- The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) ：Single-arm, Prospective, Open Clinical StudyRecruitingNCT06125080Phase 2
- Shear-wave Elastography in Breast CancerNot yet recruitingNCT06123819
- Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal SymptomsRecruitingNCT06123286Early Phase 1
- Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast CancerRecruitingNCT06121570Phase 1
- Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast CancerRecruitingNCT06121557Phase 1
- Adherence Intervention in Patients With Metastatic Breast CancerRecruitingNCT06121453Not applicable
- BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid TumorsRecruitingNCT06120283Phase 1
- The Effects of Laughter Yoga and Mindfulness-Based Stress Reduction (MBSR) Practices Applied to Women With Breast CancerRecruitingNCT06116812Not applicable
- EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast CancerRecruitingNCT06115486Not applicable
- Lymphatic Response to Resistance Exercise in Breast Cancer SurvivorsNot yet recruitingNCT06113627Not applicable
- The Effect of Web-Assisted Peer Education for Early Diagnosis of Breast Cancer on Health Beliefs, Knowledge Levels and Breast Self-Examination in University StudentsRecruitingNCT06112158Not applicable
- Use of an Ultra-rapid BRCA1/2 Status Screening Test in Diagnostic and Theranostic Indication: Performance and Interest for Patients and PractitionersRecruitingNCT06111417
- CLinical Evaluation Of a comPuter Algorithm To Report BreAst cAncers (CLEOPATRAA)Not yet recruitingNCT06110845
- TIL Therapy for Patients With Advanced Solid TumorsNot yet recruitingNCT06107894Phase 1
- A Study of YL202 in Selected Patients With Advanced Solid TumorsRecruitingNCT06107686Phase 2
- Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC）RecruitingNCT06107673Phase 2
- The Impact of Adverse Events, Produced by Antibodies Conjugates, on Quality of Life in Patients With Metastatic Breast Cancer: Multicentric, Observational Study (EVA).Not yet recruitingNCT06106711
- REDucing Hot FLASHes in Women Using Endocrine Therapy.RecruitingNCT06106529Phase 3
- Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast CancerRecruitingNCT06106477Not applicable
- Biennial CEM in Women With a Personal History of Breast CancerRecruitingNCT06105749Not applicable
- Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast CancerRecruitingNCT06105684Phase 2
- Lymph Node Identification Using Magtrace and Magseed Before ChemotherapyRecruitingNCT06104371
- 99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast CancerRecruitingNCT06104085Not applicable
- A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)RecruitingNCT06103864Phase 3
- Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)RecruitingNCT06103669Not applicable
- eHealth Interventions for Breast Cancer Cognitive ImpairmentNot yet recruitingNCT06103318Not applicable
- Organoid-based Functional Precision Therapy for Advanced Breast CancerRecruitingNCT06102824Phase 2
- Diagnostic Biomarkers Exploration of Breast Cancer From Serum and UrineRecruitingNCT06102018
- A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast CancerRecruitingNCT06099769Phase 2
- Serum Retinoic Acid Induced Protein 14 (RAI14) and Metastasis Associated Cancer Colon -1 (MACC-1) in Breast CancerNot yet recruitingNCT06097546
- Evaluation of See.d as an Automated Blood Sample Preparator for Multiple Liquid Biopsy ApplicationsRecruitingNCT06097156
- Axillary Management After Neoadjuvant ChemotherapyRecruitingNCT06096545Not applicable
- Comparing Level 1 Compression Sleeves With Routine Care in Preventing Breast Cancer-related Arm LymphedemaRecruitingNCT06095323Not applicable
- Surgical or Medical Treatment of Breast Cancer Metastasis: A Multicentre Observational StudyRecruitingNCT06093022
- IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal MetastasesRecruitingNCT06092892Phase 2
- Improving Lifestyle Behavior by "Joven, Fuerte y Saludable" Multidisciplinary Program.RecruitingNCT06090747Not applicable
- Safety of Omitting Axillary Surgery in Breast Cancer Patients With Isolated Chest Wall RecurrenceRecruitingNCT06088719
- A Phase II Study of T-DXd Plus SRT in HER2-positive Breast Cancer Brain MetastasesNot yet recruitingNCT06088056Phase 2
- Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA AssessmentRecruitingNCT06087120
- Study of 18F-FFNP Breast PET/MRIRecruitingNCT06086704Phase 2
- ARTIDIS Nanomechanical Generated Measurements for Early Breast LesionsRecruitingNCT06085833Not applicable
- BRE-08 Phase II Study of CMC Regimen for Early Stage Breast CancerRecruitingNCT06085742Phase 2
- Cancer Pain Management Using a Web-based InterventionRecruitingNCT06085313Not applicable
- Sentinel lympH Node Biopsy With Indocyanine Green in Breast Cancer After NEoadjuvant Chemotherapy (SHINE)RecruitingNCT06085274Not applicable
- Study of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast CancerRecruitingNCT06081959Phase 3
- NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III)RecruitingNCT06081244Phase 3
- The Choice of Treatment Methods and Efficacy of LABCRecruitingNCT06080620Not applicable
- PRO Survivorship Concerns ITARecruitingNCT06080607
- JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer SubjectsRecruitingNCT06079983Phase 3
- Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBCRecruitingNCT06078384Phase 2
- Palbociclib Induced Neutropenia; Risk Factors and Treatment Outcome in Metastatic Breast Cancer PatientsNot yet recruitingNCT06076772
- A Study of Oral MBQ-167 in Participants With Advanced Breast CancerRecruitingNCT06075810Phase 1
- Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer : Watch Your HeaRTRecruitingNCT06073509
- Dietary Habits, Nutritional Knowledge and Physical Activity Assessment in Early Stage Breast Cancer PatientsRecruitingNCT06073418
- Targeting Osteosarcopaenia and Multimorbidity for Frailty PreventionRecruitingNCT06073106
- Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast CancerRecruitingNCT06072807Phase 4
- Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.RecruitingNCT06072612Phase 3
- Radiotherapy Exposed Lung Injury: Effect on Functioning - CohortRecruitingNCT06069115
- Biomarkers to Detect Endocrine Therapy ResistanceRecruitingNCT06067503Phase 2
- A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.RecruitingNCT06064812Phase 1/2
- Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast CancerRecruitingNCT06062498Phase 2
- Treatment of Insomnia in Patients With Breast CancerRecruitingNCT06061666Not applicable
- Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast AbnormalitiesRecruitingNCT06058650Not applicable
- SAHARA-04 : Adaptive Radiotherapy in Hypersensitive Patients and High Locoregional Risk Breast Cancer With ETHOS TechnologyRecruitingNCT06053086Not applicable
- Strength After Breast CancerRecruitingNCT06052488Not applicable
- Investigation of the Efficiency of Pain Neuroscience Education in Patients With Chronic Pain After Breast Cancer SurgeryRecruitingNCT06052085Not applicable
- The Benefits of Continued Use of Ovarian Function Suppression After 5 YearsRecruitingNCT06050109
- EMBRACE: Exercising TogetherRecruitingNCT06049355Phase 2
- Circulating Tumour Cells Characterization in Breast Cancer PatientsRecruitingNCT06048835
- Nutritional Intervention-induced Weight Loss During the Oncological Treatment of Obesity-related Breast CancerNot yet recruitingNCT06046755Not applicable
- Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer PatientsRecruitingNCT06044623Phase 3
- A Study of SI-B003 or BL-B01D1+SI-B003 in Patients With Unresectable Locally Advanced or Recurrent Metastatic HER2 Negative Breast CancerRecruitingNCT06042894Phase 2
- De-escalating Axillary Surgery in Breast Cancer Patients in NigeriaNot yet recruitingNCT06039956Not applicable
- To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast CancerRecruitingNCT06039644Not applicable
- A Study of Mental Health Care in People With CancerRecruitingNCT06037954Not applicable
- Pyrotinib Combined With Trastuzumab and Chemotherapy Neoadjuvant Therapy for HER2-positive Breast CancerRecruitingNCT06035679Not applicable
- Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast CancerRecruitingNCT06035016
- Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC.RecruitingNCT06033287
- Artificial Intelligence in Mammography Screening in NorwayRecruitingNCT06032390Not applicable
- Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast CancerRecruitingNCT06027632Not applicable
- ACTIVPROSEIN : Professional Activity After Breast CancerRecruitingNCT06025604
- Cold Dissection Versus Electrocautery Dissection in Endoscopic Nipple-Sparing Mastectomy and Immediate Implant-Based Reconstruction: A Randomized Controlled TrialRecruitingNCT06024187Not applicable
- A Study of Blood Pressure Control During Cancer TreatmentRecruitingNCT06023576Phase 2
- A Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of ConvitVax in Metastatic Breast CancerNot yet recruitingNCT06023277Phase 1/2
- A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.RecruitingNCT06022029Phase 1
- Tucatinib, Trastuzumab and Capecitabine With Brain and/or Spinal Radiotherapy (XRT) in Patients With HER2+, HER2 Mutated and/or HER2-amplified Metastatic Breast Cancer and Leptomeningeal Disease: A Multi-centre Phase II, Single Arm Feasibility StudyRecruitingNCT06016387Phase 2
- Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer PatientsRecruitingNCT06015126Not applicable
- Efficacy and Safety of Disitamab Vedotin Plus Pyrotinib or Naratinib in HER2-positive Breast Cancer Patients With Brain MetastasisNot yet recruitingNCT06015113Not applicable
- Relative Dose Intensity of Adjuvant Chemotherapy in Older Women With ER+ HER2- Breast Cancer.Not yet recruitingNCT06010615
- Neratinib in Combination With Ruxolitinib in Patients With mTNBCRecruitingNCT06008275Early Phase 1
- Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton TherapyRecruitingNCT06006806Not applicable
- Evaluation of Improvements in Patient-reported Quality of LifeRecruitingNCT06002022Not applicable
- A Phase II Clinical Study of Treatment With Disitamb Vedotin Plus Pyrotinib in HER2-positive Early Breast CancerRecruitingNCT06001086Phase 2
- A Study of Neoadjuvant TCHpy（Pyrotinib ，Trastuzumab，Carboplatin and Paclitaxel）for ER+/HER2+ Breast CancerRecruitingNCT06000917Phase 2
- Study of Disitamab Vedotin and Anlotinib in Patients With HR-Negative, HER2-Low-Expressing Metastatic Breast CancerNot yet recruitingNCT06000033Phase 2
- FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal CancerRecruitingNCT05999396Phase 1
- A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)RecruitingNCT05999149Phase 3